25 XP   0   0   10

GeoVax Labs Inc
Buy, Hold or Sell?

Let's analyse Geovax together

PenkeI guess you are interested in GeoVax Labs Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of GeoVax Labs Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about GeoVax Labs Inc

I send you an email if I find something interesting about GeoVax Labs Inc.

Quick analysis of Geovax (30 sec.)










What can you expect buying and holding a share of Geovax? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$2.50
Expected worth in 1 year
$-33.61
How sure are you?
30.0%

+ What do you gain per year?

Total Gains per Share
$-36.11
Return On Investment
-2,542.8%

For what price can you sell your share?

Current Price per Share
$1.42
Expected price per share
$0 - $1.82
How sure are you?
50%

1. Valuation of Geovax (5 min.)




Live pricePrice per Share (EOD)

$1.42

Intrinsic Value Per Share

$-178.24 - $-77.31

Total Value Per Share

$-175.74 - $-74.81

2. Growth of Geovax (5 min.)




Is Geovax growing?

Current yearPrevious yearGrowGrow %
How rich?$5.7m$26.6m-$20.8m-361.5%

How much money is Geovax making?

Current yearPrevious yearGrowGrow %
Making money-$25.9m-$14m-$11.9m-46.0%
Net Profit Margin0.0%-17,301.9%--

How much money comes from the company's main activities?

3. Financial Health of Geovax (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#728 / 1007

Most Revenue
#684 / 1007

Most Profit
#475 / 1007

Most Efficient
#840 / 1007

What can you expect buying and holding a share of Geovax? (5 min.)

Welcome investor! Geovax's management wants to use your money to grow the business. In return you get a share of Geovax.

What can you expect buying and holding a share of Geovax?

First you should know what it really means to hold a share of Geovax. And how you can make/lose money.

Speculation

The Price per Share of Geovax is $1.42. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Geovax.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Geovax, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $2.50. Based on the TTM, the Book Value Change Per Share is $-9.03 per quarter. Based on the YOY, the Book Value Change Per Share is $9.63 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Geovax.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-11.25-792.2%-11.25-792.2%-6.07-427.8%-5.54-389.8%-3.35-235.9%
Usd Book Value Change Per Share-9.03-635.7%-9.03-635.7%9.63678.4%0.5941.4%0.149.9%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-9.03-635.7%-9.03-635.7%9.63678.4%0.5941.4%0.149.9%
Usd Price Per Share0.36-0.36-0.63-1.60-0.80-
Price to Earnings Ratio-0.03--0.03--0.10--0.64--0.32-
Price-to-Total Gains Ratio-0.04--0.04-0.07--0.18--0.08-
Price to Book Ratio0.14-0.14-0.05-0.59-0.29-
Price-to-Total Gains Ratio-0.04--0.04-0.07--0.18--0.08-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.42
Number of shares704
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-9.030.59
Usd Total Gains Per Share-9.030.59
Gains per Quarter (704 shares)-6,354.87413.89
Gains per Year (704 shares)-25,419.481,655.54
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-25419-25429016561646
20-50839-50848033113302
30-76258-76267049674958
40-101678-101686066226614
50-127097-127105082788270
60-152517-152524099339926
70-177936-17794301158911582
80-203356-20336201324413238
90-228775-22878101490014894
100-254195-25420001655516550

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%0.010.00.00.0%1.026.00.03.7%
Book Value Change Per Share0.01.00.00.0%1.02.00.033.3%2.03.00.040.0%3.07.00.030.0%12.014.01.044.4%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%0.00.010.00.0%0.00.027.00.0%
Total Gains per Share0.01.00.00.0%1.02.00.033.3%2.03.00.040.0%3.07.00.030.0%12.014.01.044.4%

Fundamentals of Geovax

About GeoVax Labs Inc

GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and solid tumor cancers using modified vaccinia ankara virus-like particle vaccine platform. It is developing various preventive vaccines against (COVID-19), human immunodeficiency virus (HIV); Zika virus; malaria; and hemorrhagic fever viruses, such as Ebola, Sudan, Marburg, and Lassa, as well as therapeutic vaccines for HIV, chronic Hepatitis B infections, and solid tumor cancers. The company is developing GEO-CM04S1, a vaccine candidate that is in Phase 2 clinical trial for the treatment of preventive COVID-19; Gedeptin, a novel patented product/technology for the treatment of solid tumors, and Phase 1/2 clinical trial for the treatment of advanced head and neck squamous cell carcinoma; and GEO-CM02, a pan-coronavirus vaccine. In addition, it is developing GEO-ZM02, a vaccine candidate, which is in preclinical trial for the treatment of GEO-ZM02, a vaccine candidate, which is in preclinical trial for the treatment of Zika; GEO-MM02 treatment for malaria; other infectious disease vaccines for the treatment of fever viruses, such as Ebola, Sudan, and Marburg; GEO-LM01 for the treatment of Lassa fever. It has collaboration and partnership agreements with the National Institute of Allergy and Infectious Diseases of the National Institutes of Health; U.S. Department of Defense; Emory University; and the Burnet Institute. GeoVax Labs, Inc. was incorporated in 1988 and is headquartered in Smyrna, Georgia.

Fundamental data was last updated by Penke on 2024-05-02 19:55:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of GeoVax Labs Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Geovax earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Geovax to the Biotechnology industry mean.
  • A Net Profit Margin of 0.0% means that $0.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of GeoVax Labs Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-17,301.9%+17,301.9%
TTM-5Y-4,495.7%+4,495.7%
5Y-4,495.7%10Y-2,427.9%-2,067.8%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--207.2%+207.2%
TTM--218.5%+218.5%
YOY-17,301.9%-282.4%-17,019.5%
5Y-4,495.7%-432.2%-4,063.5%
10Y-2,427.9%-593.8%-1,834.1%
1.1.2. Return on Assets

Shows how efficient Geovax is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Geovax to the Biotechnology industry mean.
  • -279.7% Return on Assets means that Geovax generated $-2.80 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of GeoVax Labs Inc:

  • The MRQ is -279.7%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -279.7%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-279.7%TTM-279.7%0.0%
TTM-279.7%YOY-44.7%-235.0%
TTM-279.7%5Y-203.3%-76.5%
5Y-203.3%10Y-280.1%+76.8%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-279.7%-13.2%-266.5%
TTM-279.7%-12.6%-267.1%
YOY-44.7%-11.5%-33.2%
5Y-203.3%-13.7%-189.6%
10Y-280.1%-15.5%-264.6%
1.1.3. Return on Equity

Shows how efficient Geovax is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Geovax to the Biotechnology industry mean.
  • -450.6% Return on Equity means Geovax generated $-4.51 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of GeoVax Labs Inc:

  • The MRQ is -450.6%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -450.6%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-450.6%TTM-450.6%0.0%
TTM-450.6%YOY-52.7%-397.9%
TTM-450.6%5Y-191.8%-258.8%
5Y-191.8%10Y-278.2%+86.4%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-450.6%-16.7%-433.9%
TTM-450.6%-15.8%-434.8%
YOY-52.7%-14.4%-38.3%
5Y-191.8%-19.0%-172.8%
10Y-278.2%-19.9%-258.3%

1.2. Operating Efficiency of GeoVax Labs Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Geovax is operating .

  • Measures how much profit Geovax makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Geovax to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of GeoVax Labs Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-17,319.8%+17,319.8%
TTM-5Y-4,509.0%+4,509.0%
5Y-4,509.0%10Y-2,434.8%-2,074.2%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--286.5%+286.5%
TTM--229.1%+229.1%
YOY-17,319.8%-288.4%-17,031.4%
5Y-4,509.0%-480.7%-4,028.3%
10Y-2,434.8%-624.7%-1,810.1%
1.2.2. Operating Ratio

Measures how efficient Geovax is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of GeoVax Labs Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY174.892-174.892
TTM-5Y54.702-54.702
5Y54.70210Y30.875+23.827
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-3.231-3.231
TTM-3.307-3.307
YOY174.8923.774+171.118
5Y54.7025.667+49.035
10Y30.8757.558+23.317

1.3. Liquidity of GeoVax Labs Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Geovax is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 2.24 means the company has $2.24 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of GeoVax Labs Inc:

  • The MRQ is 2.240. The company is able to pay all its short-term debts. +1
  • The TTM is 2.240. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.240TTM2.2400.000
TTM2.240YOY6.095-3.855
TTM2.2405Y4.666-2.425
5Y4.66610Y4.203+0.463
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.2403.890-1.650
TTM2.2404.182-1.942
YOY6.0955.343+0.752
5Y4.6666.135-1.469
10Y4.2036.453-2.250
1.3.2. Quick Ratio

Measures if Geovax is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Geovax to the Biotechnology industry mean.
  • A Quick Ratio of 1.83 means the company can pay off $1.83 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of GeoVax Labs Inc:

  • The MRQ is 1.833. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 1.833. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ1.833TTM1.8330.000
TTM1.833YOY5.816-3.983
TTM1.8335Y4.472-2.638
5Y4.47210Y3.996+0.475
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.8333.528-1.695
TTM1.8334.059-2.226
YOY5.8165.390+0.426
5Y4.4726.138-1.666
10Y3.9966.488-2.492

1.4. Solvency of GeoVax Labs Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Geovax assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Geovax to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.38 means that Geovax assets are financed with 37.9% credit (debt) and the remaining percentage (100% - 37.9%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of GeoVax Labs Inc:

  • The MRQ is 0.379. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.379. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.379TTM0.3790.000
TTM0.379YOY0.151+0.228
TTM0.3795Y1.120-0.741
5Y1.12010Y1.069+0.051
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3790.339+0.040
TTM0.3790.337+0.042
YOY0.1510.273-0.122
5Y1.1200.368+0.752
10Y1.0690.391+0.678
1.4.2. Debt to Equity Ratio

Measures if Geovax is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Geovax to the Biotechnology industry mean.
  • A Debt to Equity ratio of 61.1% means that company has $0.61 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of GeoVax Labs Inc:

  • The MRQ is 0.611. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.611. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.611TTM0.6110.000
TTM0.611YOY0.178+0.432
TTM0.6115Y0.516+0.095
5Y0.51610Y0.439+0.077
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6110.388+0.223
TTM0.6110.403+0.208
YOY0.1780.342-0.164
5Y0.5160.432+0.084
10Y0.4390.461-0.022

2. Market Valuation of GeoVax Labs Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Geovax generates.

  • Above 15 is considered overpriced but always compare Geovax to the Biotechnology industry mean.
  • A PE ratio of -0.03 means the investor is paying $-0.03 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of GeoVax Labs Inc:

  • The EOD is -0.126. Based on the earnings, the company is expensive. -2
  • The MRQ is -0.032. Based on the earnings, the company is expensive. -2
  • The TTM is -0.032. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.126MRQ-0.032-0.094
MRQ-0.032TTM-0.0320.000
TTM-0.032YOY-0.104+0.072
TTM-0.0325Y-0.645+0.613
5Y-0.64510Y-0.324-0.321
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.126-2.249+2.123
MRQ-0.032-2.553+2.521
TTM-0.032-2.669+2.637
YOY-0.104-4.107+4.003
5Y-0.645-6.247+5.602
10Y-0.324-6.499+6.175
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of GeoVax Labs Inc:

  • The EOD is -0.130. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -0.033. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -0.033. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.130MRQ-0.033-0.097
MRQ-0.033TTM-0.0330.000
TTM-0.033YOY-0.076+0.043
TTM-0.0335Y-0.707+0.674
5Y-0.70710Y-0.355-0.352
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.130-2.858+2.728
MRQ-0.033-3.288+3.255
TTM-0.033-3.552+3.519
YOY-0.076-5.560+5.484
5Y-0.707-8.326+7.619
10Y-0.355-8.881+8.526
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Geovax is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 0.14 means the investor is paying $0.14 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of GeoVax Labs Inc:

  • The EOD is 0.569. Based on the equity, the company is cheap. +2
  • The MRQ is 0.145. Based on the equity, the company is cheap. +2
  • The TTM is 0.145. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD0.569MRQ0.145+0.424
MRQ0.145TTM0.1450.000
TTM0.145YOY0.055+0.090
TTM0.1455Y0.586-0.441
5Y0.58610Y0.294+0.292
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD0.5691.929-1.360
MRQ0.1452.090-1.945
TTM0.1452.091-1.946
YOY0.0552.881-2.826
5Y0.5863.545-2.959
10Y0.2943.936-3.642
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of GeoVax Labs Inc.

3.1. Institutions holding GeoVax Labs Inc

Institutions are holding 9.058% of the shares of GeoVax Labs Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-09-30Vanguard Group Inc2.23560728443-2542-0.3477
2023-09-30BlackRock Inc1.2689041344400
2023-09-30Geode Capital Management, LLC0.530601728951450.0839
2023-09-30State Street Corporation0.300609794200
2023-09-30Morgan Stanley - Brokerage Accounts0.154105019700
2023-09-30Northern Trust Corp0.10503421400
2023-09-30Welch & Forbes LLC0.05220.00011699400
2023-09-30Tower Research Capital LLC0.03220.000210504-58-0.5491
2023-09-30Wells Fargo & Co0.01404568-122-2.6013
2023-12-31Global Retirement Partners, LLC.0.0012040100
2023-09-30Royal Bank of Canada0.000205000
2023-09-30JPMorgan Chase & Co0.0001032320
2023-12-31UBS Group AG000-19019-100
2023-09-30GSA Capital Partners LLP000-11328-100
2023-09-30Virtu Financial LLC000-27097-100
2023-12-31Advisor Group Holdings, Inc.000-3000-100
2023-09-30TWO SIGMA SECURITIES, LLC000-36805-100
Total 4.69470.00031529684-99794-6.5%

3.2. Funds holding GeoVax Labs Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-09-30BlackRock Extended Mkt Composite0.27110.00039385400
2023-12-31Northern Trust Extended Eq Market Idx0.05850.00012026700
2024-03-31Vanguard Institutional Extnd Mkt Idx Tr0.833501923900
2023-12-31NT Ext Equity Mkt Idx Fd - NL0.04030.00011394700
2023-12-31NT Ext Equity Mkt Idx Fd - DC - NL - T20.03230.000111201210.1878
2023-12-31SSgA U.S. Extended Market Index Class I0.02920.00011010000
2024-02-29Fidelity Extended Market Index0.34580.0001798130.0376
2024-03-31BlackRock Extended Equity Market K0.23660.0001546230.055
2023-12-31SSgA U.S. Total Market Index Strategy0.008402913-67-2.2483
2024-02-29Fidelity Series Total Market Index0.08980207210.0483
2024-03-31NT Ext Equity Mkt Idx Fd - L0.05860135210.074
2024-03-31Extended Equity Market Fund M0.02920.0001674-1-0.1481
2024-03-31State St US Extended Mkt Indx NL Cl C0.02920.000167300
2024-02-29Fidelity Total Market Index0.024055400
2023-12-31NT Ext Eq Mkt Indx Fd DC Lending Tier 50.00130.000145120.4454
2024-02-29Fidelity Nasdaq Composite Index0.0178041010.2445
2024-02-29Spartan Extended Market Index Pool E0.016036910.2717
2024-02-29Spartan Total Market Index Pool E0.0058013510.7463
2024-02-29Fidelity U.S. Equity Index Ins Trust0.00040990
Total 2.12780.0012191663-250.0%

3.3. Insider Transactions

Insiders are holding 1.589% of the shares of GeoVax Labs Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2024-02-21David A DoddBUY5202.15
2023-12-22Kelly T Jr. MckeeBUY4625.4
2023-09-25Kelly T Jr. MckeeBUY6437.8
2023-08-25David A DoddBUY23398.55
2023-08-18Mark ReynoldsBUY6667.8

4. Summary

4.1. Key Performance Indicators

The key performance indicators of GeoVax Labs Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---9.027-9.0270%9.634-194%0.588-1635%0.140-6539%
Book Value Per Share--2.4972.4970%11.524-78%3.875-36%1.991+25%
Current Ratio--2.2402.2400%6.095-63%4.666-52%4.203-47%
Debt To Asset Ratio--0.3790.3790%0.151+150%1.120-66%1.069-65%
Debt To Equity Ratio--0.6110.6110%0.178+242%0.516+18%0.439+39%
Dividend Per Share----0%-0%-0%-0%
Eps---11.249-11.2490%-6.074-46%-5.535-51%-3.349-70%
Free Cash Flow Per Share---10.927-10.9270%-8.302-24%-5.194-52%-3.725-66%
Free Cash Flow To Equity Per Share---9.167-9.1670%7.013-231%0.537-1808%-0.516-94%
Gross Profit Margin--231919.290231919.2900%1.000+23191829%46384.658+400%23192.829+900%
Intrinsic Value_10Y_max---77.310--------
Intrinsic Value_10Y_min---178.236--------
Intrinsic Value_1Y_max---4.602--------
Intrinsic Value_1Y_min---10.619--------
Intrinsic Value_3Y_max---16.225--------
Intrinsic Value_3Y_min---38.366--------
Intrinsic Value_5Y_max---30.737--------
Intrinsic Value_5Y_min---72.983--------
Market Cap3277800.200+75%833299.910833299.9100%1454696.962-43%3689371.873-77%1848494.648-55%
Net Profit Margin----0%-173.0190%-44.9570%-24.2790%
Operating Margin----0%-173.1980%-45.0900%-24.3480%
Operating Ratio----0%174.892-100%54.702-100%30.875-100%
Pb Ratio0.569+75%0.1450.1450%0.055+164%0.586-75%0.294-51%
Pe Ratio-0.126-293%-0.032-0.0320%-0.104+223%-0.645+1909%-0.324+909%
Price Per Share1.420+75%0.3610.3610%0.630-43%1.598-77%0.801-55%
Price To Free Cash Flow Ratio-0.130-293%-0.033-0.0330%-0.076+130%-0.707+2041%-0.355+975%
Price To Total Gains Ratio-0.157-293%-0.040-0.0400%0.065-161%-0.176+340%-0.079+97%
Quick Ratio--1.8331.8330%5.816-68%4.472-59%3.996-54%
Return On Assets---2.797-2.7970%-0.447-84%-2.033-27%-2.801+0%
Return On Equity---4.506-4.5060%-0.527-88%-1.918-57%-2.782-38%
Total Gains Per Share---9.027-9.0270%9.634-194%0.588-1635%0.140-6539%
Usd Book Value--5763338.0005763338.0000%26600000.000-78%8943956.400-36%4596787.300+25%
Usd Book Value Change Per Share---9.027-9.0270%9.634-194%0.588-1635%0.140-6539%
Usd Book Value Per Share--2.4972.4970%11.524-78%3.875-36%1.991+25%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---11.249-11.2490%-6.074-46%-5.535-51%-3.349-70%
Usd Free Cash Flow---25222585.000-25222585.0000%-19164466.000-24%-11988930.600-52%-8598333.500-66%
Usd Free Cash Flow Per Share---10.927-10.9270%-8.302-24%-5.194-52%-3.725-66%
Usd Free Cash Flow To Equity Per Share---9.167-9.1670%7.013-231%0.537-1808%-0.516-94%
Usd Market Cap3277800.200+75%833299.910833299.9100%1454696.962-43%3689371.873-77%1848494.648-55%
Usd Price Per Share1.420+75%0.3610.3610%0.630-43%1.598-77%0.801-55%
Usd Profit---25966762.000-25966762.0000%-14014561.000-46%-12765254.000-51%-7725097.500-70%
Usd Revenue----0%81000.000-100%692979.200-100%764312.100-100%
Usd Total Gains Per Share---9.027-9.0270%9.634-194%0.588-1635%0.140-6539%
 EOD+5 -3MRQTTM+0 -0YOY+3 -295Y+6 -2610Y+10 -22

4.2. Fundamental Score

Let's check the fundamental score of GeoVax Labs Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.126
Price to Book Ratio (EOD)Between0-10.569
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than11.833
Current Ratio (MRQ)Greater than12.240
Debt to Asset Ratio (MRQ)Less than10.379
Debt to Equity Ratio (MRQ)Less than10.611
Return on Equity (MRQ)Greater than0.15-4.506
Return on Assets (MRQ)Greater than0.05-2.797
Total5/10 (50.0%)

4.3. Technical Score

Let's check the technical score of GeoVax Labs Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose1.430
Total1/1 (100.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets9,283
Total Liabilities3,520
Total Stockholder Equity5,763
 As reported
Total Liabilities 3,520
Total Stockholder Equity+ 5,763
Total Assets = 9,283

Assets

Total Assets9,283
Total Current Assets7,886
Long-term Assets1,397
Total Current Assets
Cash And Cash Equivalents 6,453
Other Current Assets 1,433
Total Current Assets  (as reported)7,886
Total Current Assets  (calculated)7,886
+/-0
Long-term Assets
Property Plant Equipment 210
Long-term Assets Other 1,188
Long-term Assets  (as reported)1,397
Long-term Assets  (calculated)1,397
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities3,520
Long-term Liabilities0
Total Stockholder Equity5,763
Total Current Liabilities
Accounts payable 2,803
Other Current Liabilities 717
Total Current Liabilities  (as reported)3,520
Total Current Liabilities  (calculated)3,520
+/-0
Long-term Liabilities
Long-term Liabilities  (as reported)0
Long-term Liabilities  (calculated)0
+/-0
Total Stockholder Equity
Common Stock2
Retained Earnings -104,364
Other Stockholders Equity 110,125
Total Stockholder Equity (as reported)5,763
Total Stockholder Equity (calculated)5,763
+/-0
Other
Capital Stock2
Cash and Short Term Investments 6,453
Common Stock Shares Outstanding 1,817
Liabilities and Stockholders Equity 9,283
Net Debt -6,453
Net Invested Capital 5,763
Net Working Capital 4,366
Property Plant and Equipment Gross 890



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-312002-12-312001-12-312000-12-311999-12-311998-12-311997-12-311996-12-31
> Total Assets 
3,403
7,269
6,720
3,372
11,161
3,917
371
172
19
19
2,396
3,246
3,056
4,316
2,358
1,645
1,478
2,840
1,333
1,332
610
490
642
469
10,394
11,797
31,348
9,283
9,28331,34811,79710,3944696424906101,3321,3332,8401,4781,6452,3584,3163,0563,2462,39619191723713,91711,1613,3726,7207,2693,403
   > Total Current Assets 
3,287
5,675
3,792
1,717
3,553
1,352
0
172
19
19
2,126
3,031
2,802
3,881
1,602
1,418
1,344
2,698
1,225
1,237
544
448
620
447
10,235
11,629
28,939
7,886
7,88628,93911,62910,2354476204485441,2371,2252,6981,3441,4181,6023,8812,8023,0312,126191917201,3523,5531,7173,7925,6753,287
       Cash And Cash Equivalents 
389
3,621
56
31
2,683
725
0
0
8
8
2,088
1,990
2,191
3,516
1,079
1,168
1,036
2,514
1,102
1,060
454
313
260
283
9,884
11,424
27,613
6,453
6,45327,61311,4249,8842832603134541,0601,1022,5141,0361,1681,0793,5162,1911,9902,08888007252,68331563,621389
       Net Receivables 
2
463
736
125
343
70
0
3
0
0
0
991
311
320
474
184
266
141
79
120
28
60
122
69
183
49
0
0
00491836912260281207914126618447432031199100030703431257364632
       Inventory 
2,652
1,531
2,954
1,522
506
518
0
3
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-122
0
-183
-49
0
0
00-49-1830-12200000000000000305185061,5222,9541,5312,652
       Other Current Assets 
232
20
47
39
21
38
0
166
11
9
38
50
299
45
49
67
42
44
45
57
62
76
360
95
351
205
1,326
1,433
1,4331,32620535195360766257454442674945299503891116603821394720232
   > Long-term Assets 
116
1,595
2,928
1,655
7,608
2,565
0
0
0
0
270
216
254
435
756
227
133
141
108
95
66
42
22
22
159
168
2,409
1,397
1,3972,409168159222242669510814113322775643525421627000002,5657,6081,6552,9281,595116
       Property Plant Equipment 
116
740
1,674
1,365
1,478
1,825
0
0
0
0
105
75
139
344
248
176
102
120
97
84
55
31
22
11
159
168
2,409
210
2102,4091681591122315584971201021762483441397510500001,8251,4781,3651,674740116
       Goodwill 
0
855
767
0
5,088
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000005,08807678550
       Intangible Assets 
0
0
0
0
5,087
0
0
0
0
0
164
139
115
90
65
40
20
10
0
0
0
0
0
0
0
0
0
0
00000000001020406590115139164000005,0870000
       Other Assets 
0
0
0
0
753
740
371
0
0
0
1
1
1
1
442
11
11
11
11
11
11
11
11
11
11
11
2,174
0
02,174111111111111111111111144211110003717407530000
> Total Liabilities 
310
1,594
3,834
2,820
640
1,869
1,010
3,989
4,965
4,965
193
599
346
571
522
942
327
312
187
127
370
811
1,664
2,043
825
7,435
4,748
3,520
3,5204,7487,4358252,0431,6648113701271873123279425225713465991934,9654,9653,9891,0101,8696402,8203,8341,594310
   > Total Current Liabilities 
267
1,248
3,531
2,635
538
672
0
3,987
2,560
2,560
193
599
346
571
522
942
327
312
187
127
370
811
1,625
2,016
810
5,435
4,748
3,520
3,5204,7485,4358102,0161,6258113701271873123279425225713465991932,5602,5603,98706725382,6353,5311,248267
       Short-term Debt 
0
171
1,213
713
167
83
0
1,312
1,164
1,164
0
0
0
0
0
0
0
0
0
0
0
0
260
13
183
0
0
0
000183132600000000000001,1641,1641,3120831677131,2131710
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
260
13
183
0
0
0
000183132600000000000000000000000
       Accounts payable 
204
791
2,104
1,895
290
478
0
133
69
69
84
547
346
408
339
138
164
156
56
101
76
78
126
153
268
2,058
1,748
2,803
2,8031,7482,05826815312678761015615616413833940834654784696913304782901,8952,104791204
       Other Current Liabilities 
62
286
215
27
80
8
0
2,173
1,328
1,004
109
51
170
571
522
803
163
156
131
26
294
734
1,239
1,851
359
3,378
3,000
717
7173,0003,3783591,8511,23973429426131156163803522571170511091,0041,3282,17308802721528662
   > Long-term Liabilities 
43
346
303
185
102
1,197
0
3
2,405
2,405
0
0
0
0
0
0
0
0
0
0
0
0
40
27
15
2,000
1,748
0
01,7482,0001527400000000000002,4052,405301,19710218530334643
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,000
0
0
002,0000000000000000000000000000
> Total Stockholder Equity
3,093
5,676
2,885
552
10,521
2,049
-639
-3,817
-4,946
-4,946
2,203
2,648
2,710
3,744
1,836
704
1,151
2,527
1,146
1,205
240
-321
-1,022
-1,575
9,569
4,362
26,600
5,763
5,76326,6004,3629,569-1,575-1,022-3212401,2051,1462,5271,1517041,8363,7442,7102,6482,203-4,946-4,946-3,817-6392,04910,5215522,8855,6763,093
   Common Stock
32
37
40
52
62
64
0
83
99
99
711
732
747
782
16
16
19
24
32
32
55
107
219
0
4
6
26
2
226640219107553232241916167827477327119999830646252403732
   Retained Earnings -104,364-78,397-64,376-45,806-42,848-40,477-37,917-35,747-32,475-29,786-27,052-24,767-22,632-20,285-17,538-14,254-10,525-6,284-70,126-70,126-67,9180-59,594-47,644-38,827-29,520-23,389-19,401
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
55,295
0
0
0
00055,295000000000000000000000000
   Treasury Stock0000000000000000000000000000
   Other Stockholders Equity 
22,462
29,027
32,366
39,327
58,103
61,579
-639
64,018
65,081
65,081
7,823
12,518
16,329
20,678
22,378
23,319
25,587
28,239
30,824
32,588
34,915
35,590
37,928
39,340
55,295
68,732
104,971
110,125
110,125104,97168,73255,29539,34037,92835,59034,91532,58830,82428,23925,58723,31922,37820,67816,32912,5187,82365,08165,08164,018-63961,57958,10339,32732,36629,02722,462



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue0
Cost of Revenue-74
Gross Profit-74-74
 
Operating Income (+$)
Gross Profit-74
Operating Expense-26,669
Operating Income-26,743-26,743
 
Operating Expense (+$)
Research Development20,721
Selling General Administrative6,022
Selling And Marketing Expenses6,022,167,052
Operating Expense26,6696,022,193,795
 
Net Interest Income (+$)
Interest Income679
Interest Expense-0
Other Finance Cost-0
Net Interest Income679
 
Pretax Income (+$)
Operating Income-26,743
Net Interest Income679
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-25,967-27,519
EBIT - interestExpense = -26,743
-25,967
-25,967
Interest Expense0
Earnings Before Interest and Taxes (EBIT)-26,743-25,967
Earnings Before Interest and Taxes (EBITDA)-26,669
 
After tax Income (+$)
Income Before Tax-25,967
Tax Provision-0
Net Income From Continuing Ops-23,758-25,967
Net Income-25,967
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses26,743
Total Other Income/Expenses Net776-679
 

Technical Analysis of Geovax
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Geovax. The general trend of Geovax is UNKNOWN with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Geovax's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator StateBullish trend Bearish trend
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of GeoVax Labs Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 1.45 < 1.82 < 1.82.

The bearish price targets are: .

Tweet this
GeoVax Labs Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of GeoVax Labs Inc. The current mas is .

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

GeoVax Labs Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of GeoVax Labs Inc.

GeoVax Labs Inc Daily Moving Average Convergence/Divergence (MACD) ChartGeoVax Labs Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of GeoVax Labs Inc. The current adx is .

GeoVax Labs Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of GeoVax Labs Inc.

GeoVax Labs Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of GeoVax Labs Inc.

GeoVax Labs Inc Daily Relative Strength Index (RSI) ChartGeoVax Labs Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of GeoVax Labs Inc.

GeoVax Labs Inc Daily Stochastic Oscillator ChartGeoVax Labs Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of GeoVax Labs Inc.

GeoVax Labs Inc Daily Commodity Channel Index (CCI) ChartGeoVax Labs Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of GeoVax Labs Inc.

GeoVax Labs Inc Daily Chande Momentum Oscillator (CMO) ChartGeoVax Labs Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of GeoVax Labs Inc.

GeoVax Labs Inc Daily Williams %R ChartGeoVax Labs Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of GeoVax Labs Inc.

GeoVax Labs Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of GeoVax Labs Inc.

GeoVax Labs Inc Daily Average True Range (ATR) ChartGeoVax Labs Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of GeoVax Labs Inc.

GeoVax Labs Inc Daily On-Balance Volume (OBV) ChartGeoVax Labs Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of GeoVax Labs Inc.

GeoVax Labs Inc Daily Money Flow Index (MFI) ChartGeoVax Labs Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for GeoVax Labs Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-12STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-13STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-14STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-19MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-12-20RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2023-12-21MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2023-12-22CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-27DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2023-12-28DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-02DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-03MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-04STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-05CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-10CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-11MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-16WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-17DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-18MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-25STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-26RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-29STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-30MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-31BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-12SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-13STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-14SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-02-16MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-23MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-27SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-28CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-05SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-11RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-03-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-13RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-19RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-20STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-25STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-03STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-04DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-05STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-10DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-11SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-12STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-16MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-04-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-22RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-04-24MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-04-25STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-26MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-04-29MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-30STOCH LONG EXITThe %K line crosses below the %D line.
2024-05-01RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

GeoVax Labs Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of GeoVax Labs Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose1.430
Total1/1 (100.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Geovax with someone you think should read this too:
  • Are you bullish or bearish on Geovax? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Geovax? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about GeoVax Labs Inc

I send you an email if I find something interesting about GeoVax Labs Inc.


Comments

How you think about this?

Leave a comment

Stay informed about GeoVax Labs Inc.

Receive notifications about GeoVax Labs Inc in your mailbox!